RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer

The influence of mRNA splicing on colon cancer development and progression is unclear. In this study, the authors demonstrate that the SRSF1 splicing factor is essential to sustain the stem cell phenotype of WNT-activated colorectal cancers.

שמור ב:
מידע ביבליוגרפי
Main Authors: Adam E. Hall, Sebastian Öther-Gee Pohl, Patrizia Cammareri, Stuart Aitken, Nicholas T. Younger, Michela Raponi, Caroline V. Billard, Alfonso Bolado Carrancio, Aslihan Bastem, Paz Freile, Fiona Haward, Ian R. Adams, Javier F. Caceres, Paula Preyzner, Alex von Kriegsheim, Malcolm G. Dunlop, Farhat V. Din, Kevin B. Myant
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Portfolio 2022-05-01
סדרה:Nature Communications
גישה מקוונת:https://doi.org/10.1038/s41467-022-30489-z
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים